European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach
United European Gastroenterology Journal · 2025-12 · 13 (10) · 1855-1886
DOI: 10.1002/ueg2.70119 ↗Kurz gefasst
Leitlinie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 26.09.2025. Verfasst von Abdulbaqi Al-Toma und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, the Netherlands. Hauptthemen laut MEDLINE: Celiac Disease. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Since the publication of the first European Society for the Study of Coeliac Disease (ESsCD) guidelines in 2019, significant advancements have emerged in the diagnosis of coeliac disease (CeD) in adults. These 2025 guidelines incorporate new evidence to refine diagnostic strategies, aiming for improved accuracy of testing, and enhance overall quality of clinical care.
Methods
A multidisciplinary panel of experts revised the ESsCD guidelines using the AGREE II instrument (Appraisal of Guidelines for Research and Evaluation II) and the GRADE methodology (The Grading of Recommendations Assessment, Development, and Evaluation). Clinical questions were structured using the PICO format, and statements and recommendations were finalised through a Delphi consensus process. Literature quality was assessed using AMSTAR‐2 and QUADAS‐2 tools.
Results
The updated guidelines are presented in two parts. Part 1 focuses on adult CeD diagnosis, introducing major changes such as a conditional no‐biopsy approach for selected adults with high‐titre IgA anti‐TG2 serology (≥ 10 × ULN). Regarding serology, the use of validated high‐performance ELISAs displaying a high diagnostic accuracy is emphasised, while routine use of IgA anti‐Endomysium serology is no longer recommended for confirmation. Revised duodenal biopsy protocols now mandate at least four samples from the second part of the duodenum, with bulb biopsies conditionally included. The guidelines provide structured approaches for diagnosing potential CeD, seronegative villous atrophy, and CeD in individuals already on a gluten‐free diet. HLA‐DQ2/DQ8 typing is recommended for diagnostic clarification in select cases.
Conclusions
The updated 2025 ESsCD guidelines provide a comprehensive framework for the diagnosis of CeD in adults. By integrating evolving diagnostic strategies, minimising over‐testing, and patient‐centred care approaches, they aim to optimise patient outcomes, quality of life and use of diagnostic resources at the same time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, the Netherlands.
- Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
- Unit of Gastroenterology, Azienda Ospedale Università Padova, Padua, Italy.
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany.
- Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
- Istituti Clinici Scientifici Maugeri IRCCS, Gastroenterology Unit of Pavia Institute, Pavia, Italy.
ORCID-Profile: Abdulbaqi Al-Toma, Fabiana Zingone, Federica Branchi, Annalisa Schiepatti, Honoria Ocagli, Nick Trott, Luca Elli, Alina Popp, David S Sanders, Gerd Bouma, Knut E A Lundin, Ludvig M Sollid, Michael Schumann
Zitieren
APA
Al-Toma, A., Zingone, F., Branchi, F., Schiepatti, A., Malamut, G., Canova, C., Rosato, I., Ocagli, H., Trott, N., Elli, L., Popp, A., Gianfrani, C., Auricchio, R., Neefjes-Borst, A., Sanders, D. S., Cellier, C., Mulder, C. J., Bouma, G., Lundin, K. E. A., …, & Schumann, M. (2025). European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach. United European Gastroenterology Journal, 13(10), 1855-1886. https://doi.org/10.1002/ueg2.70119
Vancouver
Al-Toma A, Zingone F, Branchi F, Schiepatti A, Malamut G, Canova C, et al. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach. United European Gastroenterology Journal. 2025;13(10):1855-1886. doi:10.1002/ueg2.70119
BibTeX
@article{AlToma2025,
author = {Al-Toma, Abdulbaqi and Zingone, Fabiana and Branchi, Federica and Schiepatti, Annalisa and Malamut, Georgia and Canova, Cristina and Rosato, Isabella and Ocagli, Honoria and Trott, Nick and Elli, Luca and Popp, Alina and Gianfrani, Carmen and Auricchio, Renata and Neefjes-Borst, Andra and Sanders, David S and Cellier, Christophe and Mulder, Chris J and Bouma, Gerd and Lundin, Knut E A and Sollid, Ludvig M and Schumann, Michael},
title = {European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach},
journal = {United European Gastroenterology Journal},
year = {2025},
volume = {13},
number = {10},
pages = {1855--1886},
doi = {10.1002/ueg2.70119}
}
EUVIMED